SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties. (2020)
Attributed to:
Development of recombinant surfactant protein D therapy to prevent neonatal chronic lung disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2020.622598
PubMed Identifier: 33542724
Publication URI: http://europepmc.org/abstract/MED/33542724
Type: Journal Article/Review
Volume: 11
Parent Publication: Frontiers in immunology
ISSN: 1664-3224